- Home
- SLM vs INDV Comparison
SLM vs INDV Comparison
Compare SLM & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLM | INDV |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SLM | INDV |
|---|---|---|
| Price | $27.08 | $34.94 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $31.09 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 1.9M |
| Earning Date | 04-23-2026 | 06-08-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | 29.10 | ★ 8100.00 |
| EPS | ★ 1.85 | 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $3.35 | N/A |
| Revenue Next Year | $5.68 | N/A |
| P/E Ratio | ★ $14.34 | $20.90 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $17.77 | $22.22 |
| 52 Week High | $31.06 | $42.81 |
Technical Indicators
Market Signals| Indicator | SLM | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 32.20 |
| Support Level | $25.78 | $32.06 |
| Resistance Level | $28.24 | $35.54 |
| Average True Range (ATR) | 0.64 | 1.05 |
| MACD | -0.14 | -0.22 |
| Stochastic Oscillator | 37.37 | 10.23 |
Price Performance
Historical ComparisonAbout SLM SLM Corporation
SLM Corp is an education solutions company. Its business is to originate and service loans to students and their families to finance the cost of their education. The term' Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).